KIR x ICOS Modulator(Mozart Therapeutics)

N/A

Report date: 2024/05/13 14:30:18

Base Information

Drug NameKIR x ICOS Modulator(Mozart Therapeutics)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 8 modulators

TargetsCluster of differentiation 8

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMozart Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesMozart Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

Other Information

ATC CodeN/A